HTG Molecular Diagnostics, Inc.
HTGMQ
$0.0001
$0.000.00%
| 03/31/2023 | 12/31/2022 | ||||
|---|---|---|---|---|---|
| Revenue | -57.67% | 95.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -57.67% | 95.00% | |||
| Cost of Revenue | -22.79% | 67.02% | |||
| Gross Profit | -51.95% | -27.73% | |||
| SG&A Expenses | -5.42% | 2.06% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.78% | 26.70% | |||
| Operating Income | -7.69% | -7.05% | |||
| Income Before Tax | -7.76% | -3.85% | |||
| Income Tax Expenses | -45.00% | 150.00% | |||
| Earnings from Continuing Operations | -7.72% | -3.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.72% | -3.91% | |||
| EBIT | -7.69% | -7.05% | |||
| EBITDA | -8.17% | -8.08% | |||
| EPS Basic | 48.96% | 8.82% | |||
| Normalized Basic EPS | 50.04% | 6.84% | |||
| EPS Diluted | 48.96% | 8.82% | |||
| Normalized Diluted EPS | 50.04% | 6.84% | |||
| Average Basic Shares Outstanding | 111.03% | 13.96% | |||
| Average Diluted Shares Outstanding | 111.03% | 13.96% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
